> Teva expects to restart production at its Irvine, CA, plant next month, following a remediation effort prompted by a December 2009 warning letter. Story
> Life sciences artwork management firm Kallik says that human error and incomplete product data have a big effect on production; poor coordination between the creative and technical sides of the house lengthens review cycles and generates unnecessary rework. Article
> An RFID pilot for track and trace at the item, pack and pallet level has been completed by Argentinean drugmaker Laboratorios Gador. Story
> CMO ScinoPharm in Taiwan will make vilazodone hydrochloride, the active ingredient in Clinical Data's just approved antidepressant, Viibryd. Item
> High tech electronics may provide a role model for the biopharma supply chain. Column
> The U.S. Trade and Development Agency is organizing a two-week trade mission to connect Indian drug executives and officials with U.S. cold chain suppliers and manufacturers. Article
> Contract manufacturer Helix plans to begin construction of a manufacturing plant in Costa Rica. Story
> Felten has designed and built a manufacturing facility for Czech-based Lonza Biotec, boosting fermentation capacities by 50 percent. Story